We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$97.6B
AUM Growth
-$1.7B
Cap. Flow
-$3.16B
Cap. Flow %
-3.24%
Top 10 Hldgs %
14.39%
Holding
3,772
New
78
Increased
2,174
Reduced
812
Closed
154

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$382M
2
HSP
HOSPIRA INC
HSP
+$235M
3
MRK icon
Merck
MRK
+$227M
4
AGN
Allergan Inc
AGN
+$199M
5
AXP icon
American Express
AXP
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 19.47%
2 Financials 16.8%
3 Industrials 9.81%
4 Technology 8.84%
5 Energy 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMEM
2726
DELISTED
VIOLIN MEMORY, INC.
VMEM
$177K ﹤0.01%
11,737
+1,550
+15% +$24.7K
IO
2727
DELISTED
ION Geophysical Corporation
IO
$177K ﹤0.01%
5,449
+706
+15% +$25.3K
BFIN
2728
DELISTED
BankFinancial
BFIN
$176K ﹤0.01%
13,422
+1,735
+15% +$20.7K
CSS
2729
DELISTED
CSS Industries, Inc.
CSS
$176K ﹤0.01%
5,823
+772
+15% +$22.1K
OMED
2730
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$176K ﹤0.01%
6,827
-18,353
-73% -$466K
ADVM
2731
DELISTED
Adverum Biotechnologies
ADVM
$175K ﹤0.01%
431
-4,957
-92% -$2.1M
PCTY icon
2732
Paylocity
PCTY
$7.43B
$175K ﹤0.01%
6,105
+2,816
+86% +$77.5K
SNC
2733
DELISTED
State National Companies, Inc.
SNC
$175K ﹤0.01%
17,572
+3,427
+24% +$34.2K
KLIC icon
2734
Kulicke & Soffa
KLIC
$4.76B
$174K ﹤0.01%
11,109
LCTX icon
2735
Lineage Cell Therapeutics
LCTX
$267M
$174K ﹤0.01%
43,431
+4,644
+12% +$16.1K
LMNR icon
2736
Limoneira
LMNR
$245M
$174K ﹤0.01%
7,980
+1,128
+16% +$24.4K
RGLS
2737
DELISTED
Regulus Therapeutics
RGLS
$174K ﹤0.01%
86
+12
+16% +$26.1K
ARO
2738
DELISTED
Aeropostale Inc
ARO
$174K ﹤0.01%
50,222
+5,299
+12% +$16.9K
MLR icon
2739
Miller Industries
MLR
$584M
$173K ﹤0.01%
7,056
+473
+7% +$10.2K
MGI
2740
DELISTED
MoneyGram International, Inc. New
MGI
$173K ﹤0.01%
20,055
+2,955
+17% +$25.7K
IMMR icon
2741
Immersion
IMMR
$254M
$172K ﹤0.01%
18,698
-25,372
-58% -$224K
BV
2742
DELISTED
Bazaarvoice, Inc.
BV
$172K ﹤0.01%
30,501
+3,928
+15% +$30.2K
KTOS icon
2743
Kratos Defense & Security Solutions
KTOS
$9.12B
$171K ﹤0.01%
30,895
+4,097
+15% +$22.1K
RDI icon
2744
Reading International Class A
RDI
$33.2M
$171K ﹤0.01%
12,742
+1,563
+14% +$19.9K
VHC icon
2745
VirnetX Holding Corp
VHC
$54.4M
$171K ﹤0.01%
1,408
+220
+19% +$26.1K
TCS
2746
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$171K ﹤0.01%
599
+104
+21% +$29.6K
HCOM
2747
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
$170K ﹤0.01%
6,377
+762
+14% +$20.1K
IBTX
2748
DELISTED
Independent Bank Group, Inc.
IBTX
$170K ﹤0.01%
4,379
+832
+23% +$29.7K
CZNC icon
2749
Citizens & Northern Corp
CZNC
$450M
$169K ﹤0.01%
8,378
+1,052
+14% +$20.8K
GEF icon
2750
Greif
GEF
$4.74B
$169K ﹤0.01%
4,302

Similar funds

BlackRock Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, BlackRock Advisors held 3,772 positions worth $97.6B, down 1.7% from $99.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors withdrew a net $3.16B in Q1 2015, closing 154 positions and reducing 812 holdings. Its most notable exit was Allergan Inc, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

Against the trend, BlackRock Advisors opened a new position in Mobileye N.V. worth $252M.

  • BlackRock Advisors's largest Q1 2015 buy was Mobileye N.V.: 6,000,666 shares worth $252M.
  • BlackRock Advisors added most to UnitedHealth in Q1 2015, an estimated $461M increase.
  • BlackRock Advisors's biggest Q1 2015 reduction was Chevron, cutting an estimated $382M.
  • BlackRock Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $199M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $97.6B portfolio in Q1 2015.
  • BlackRock Advisors opened 78 new positions and closed 154 in Q1 2015.
  • BlackRock Advisors's portfolio value fell 1.7% quarter-over-quarter to $97.6B.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.